A PYMNTS Company

EU: Baxter, Gambro dialysis merger to clear following major divesture

By  |  July 10, 2013

A merger between US-based healthcare conglomerate Baxter and Sweden-based medical technologies company Gambro will be cleared by the European Commission, say reports. The agreement, signed at $4 billion, was modified when Baxter agreed to divest part of the company worth about one-fifth of its annual turnover, said two unnamed sources. Clearance from the European Commission would make the company the second-largest dialysis equipment manufacturer; reports say the global market is set to grow as obesity and diabetes rates climb. The two companies announced the deal last December.

Full Content: Chicago Tribune

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.